Tomas Rees, PhD, Oxford PharmaGenesis Ltd, Oxford, UK; Stacy Konkiel, MLS/MIS, Altmetric, Farringdon, London, UK; Andrew Shepherd, PhD, Envision Pharma Group, Horsham, UK This article was derived from the efforts of the ISMPP Social Media and Web-based Metrics Working...
Katherine Baria, BSc (ARCS), PhD, AstraZeneca, Gaithersburg, MD, USA; Richard Baker, ISMPP CMPP™, BSc (Hons), Novartis, Basel, Switzerland; Claire Bartlett, ISMPP CMPP™, BA (Hons), CMC Connect, McCann Health Medical Communications, Macclesfield, UK; Belinda Dean,...
Laurie Myers, MBA, Merck & Co., Inc. Communicating with patients about clinical trials is challenging in today’s increasingly complex world of treatment options. While access to information about clinical trials is more widely available, patients with serious...
“The only constant is change,” attributed to Heraclitus ca 500 BC, holds true for medical publication professionals in the 21st century. At times, it may feel like every week brings an announcement of a new regulation, guideline, protocol, or requirement, and we must...
Karen D. Mittleman, PhD; Allison M. Galway, MS, ISMPP CMPP™, Chameleon, a member of Omnicom and Healthcare Consultancy Group, New York, NY, USA; Jason Gardner, PhD, ISMPP CMPP™, CMC Connect, McCann Health Medical Communications, Macclesfield, UK; Lana Vegman, PharmD,...
Leanne Larson, MHA, Corporate Vice President and Worldwide Head, Real-World Evidence, Parexel International, USA* Interviewed by Sally Hassan, PhD, ISMPP CMPP™, Parexel International, UK. * The opinions expressed within are the author’s own and do not necessarily...
